GURUFOCUS.COM » STOCK LIST » Healthcare » Biotechnology » Avalo Therapeutics Inc (STU:C6K0) » Definitions » Price-to-Tangible-Book

Avalo Therapeutics (STU:C6K0) Price-to-Tangible-Book : 0.33 (As of May. 24, 2025)


View and export this data going back to 2021. Start your Free Trial

What is Avalo Therapeutics Price-to-Tangible-Book?

As of today (2025-05-24), Avalo Therapeutics's share price is €3.185. Avalo Therapeutics's Tangible Book per Share of Mar. 2025 for the quarter that ended in Mar. 2025 was €9.58. Hence, Avalo Therapeutics's Price to Tangible Book Ratio of today is 0.33.

The historical rank and industry rank for Avalo Therapeutics's Price-to-Tangible-Book or its related term are showing as below:

STU:C6K0' s Price-to-Tangible-Book Range Over the Past 10 Years
Min: 0.35   Med: 36.75   Max: 10727.85
Current: 0.35

During the past 12 years, Avalo Therapeutics's highest Price to Tangible Book Ratio was 10727.85. The lowest was 0.35. And the median was 36.75.

STU:C6K0's Price-to-Tangible-Book is ranked better than
95.57% of 1197 companies
in the Biotechnology industry
Industry Median: 2.69 vs STU:C6K0: 0.35

A closely related ratio is called PB Ratio. As of today, Avalo Therapeutics's share price is €3.185. Avalo Therapeutics's Book Value per Sharefor the quarter that ended in Mar. 2025 was €10.48. Hence, Avalo Therapeutics's P/B Ratio of today is 0.30.


Avalo Therapeutics Price-to-Tangible-Book Historical Data

The historical data trend for Avalo Therapeutics's Price-to-Tangible-Book can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Avalo Therapeutics Price-to-Tangible-Book Chart

Avalo Therapeutics Annual Data
Trend Dec15 Dec16 Dec17 Dec18 Dec19 Dec20 Dec21 Dec22 Dec23 Dec24
Price-to-Tangible-Book
Get a 7-Day Free Trial Premium Member Only Premium Member Only - 20.58 - - 0.70

Avalo Therapeutics Quarterly Data
Jun20 Sep20 Dec20 Mar21 Jun21 Sep21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23 Sep23 Dec23 Mar24 Jun24 Sep24 Dec24 Mar25
Price-to-Tangible-Book Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only - - 8.23 0.70 0.78

Competitive Comparison of Avalo Therapeutics's Price-to-Tangible-Book

For the Biotechnology subindustry, Avalo Therapeutics's Price-to-Tangible-Book, along with its competitors' market caps and Price-to-Tangible-Book data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


Avalo Therapeutics's Price-to-Tangible-Book Distribution in the Biotechnology Industry

For the Biotechnology industry and Healthcare sector, Avalo Therapeutics's Price-to-Tangible-Book distribution charts can be found below:

* The bar in red indicates where Avalo Therapeutics's Price-to-Tangible-Book falls into.


;
;

Avalo Therapeutics Price-to-Tangible-Book Calculation

Avalo Therapeutics's price-to-tangible-book ratio for today is calculated as:

Price to Tangible Book=Share Price/Tangible Book per Share (Q: Mar. 2025 )
=3.185/9.577
=0.33

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

It can also be calculated from the numbers for the whole company:

A closely related ratio is called PB Ratio. The difference between Price-to-Tangible-Book Ratio and PB Ratio is that book value other than intangibles are used in the calculation.


Be Aware

Some businesses have very light assets, such as software companies or insurance agencies. The Price-to-Book Ratio does not work well for these companies. Some companies even have negative equity, so the Price-to-Book Ratio cannot be applied to them.


Avalo Therapeutics Price-to-Tangible-Book Related Terms

Thank you for viewing the detailed overview of Avalo Therapeutics's Price-to-Tangible-Book provided by GuruFocus.com. Please click on the following links to see related term pages.


Avalo Therapeutics Business Description

Traded in Other Exchanges
Address
540 Gaither Road, Suite 400, Rockville, MD, USA, 20850
Avalo Therapeutics Inc is a clinical-stage biotechnology company focused on the treatment of immune dysregulation. The company's asset is AVTX-009, an anti-IL-1B monoclonal antibody ("mAb"), targeting inflammatory diseases. Avalo's pipeline also includes quisovalimab (anti-LIGHT mAb) and AVTX-008 (BTLA agonist fusion protein).

Avalo Therapeutics Headlines

No Headlines